Diversity, Equity and Inclusion in Advanced Therapies

Diversity, Equity and Inclusion in Advanced Therapies

Phacilitate are committed to creating an environment that is safe, professional and which values diversity and inclusion for all.
Phacilitate are committed to creating an environment that is safe, professional and which values diversity and inclusion for all. Every event participant, whether speaker, attendee, sponsor or staff is entitled to be treated fairly, with courtesy and respect.

Additionally, our sector demands innovation and currently we lack the diversity that can help us achieve our full potential.
 
Through a truly inclusive culture we can get there faster and with better outcomes.

Our code of conduct which is present at all of our events is intended to lay the ground for creating an open and inclusive event environment that fosters equitable, enjoyable and productive discussion and collaboration.

In 2015, we launched Women in Advanced Therapies a mentorship and networking community for women working in cell and gene therapy. We're delighted to have paired 22 mentors and mentees since the program started. And several new connections through our networking lunch and learns. 

In 2018 we set a target to achieve a 33% female speaker panel. We're delighted we achieved this goal and will continue to set targets and do better in fixing the gender imbalance and racial imbalance in science and biotech.

In 2019 we sponsored a young black undergraduate from Georgia Institute of Technology to travel and attend Advanced Therapies Week. You can read about Edward Freeman's journey through advanced therapies here. In 2021 and beyond, we will continue to sponsor science students from black and other underrepresented groups to attend our conferences. Creating equity, levelling the playing field and creating chances where it is otherwise lacking.
 


In 2020, we launched The Future of Medicine Day. Held on Martin Luther King Junior Day, we took over the Frost Science Museum to introduce the next generation to science.

Through our continued focus and initiatives, we hope to inspire our industry be better, challenge systemic injustice and spark inclusive collaboration and practice allyship.